首页> 外文OA文献 >Overexpression of EGFR pathway-related genes in the circulation is highly correlated with EGFR mutations and overexpression in paired cancer tissue from patients with non-small cell lung cancer

【2h】

Overexpression of EGFR pathway-related genes in the circulation is highly correlated with EGFR mutations and overexpression in paired cancer tissue from patients with non-small cell lung cancer

机译：循环中的EGFR途径相关基因的过表达与来自非小细胞肺癌的患者的配对癌组织中的EGFR突变和过表达高度相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Overexpression of EGFR pathway-related genes in the circulation is highly correlated with EGFR mutations and overexpression in paired cancer tissue from patients with non-small cell lung cancer. [J] . Chen CC, Chiu HH, Yen LC, Oncology reports . 2010,第3期

机译：EGFR通路相关基因在循环中的过表达与非小细胞肺癌患者配对癌组织中的EGFR突变和过表达高度相关。
2. Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? No, EGFR TKIs should be reserved for patients with EGFR mutations. [J] . Gregory J Riely Clinical advances in hematology & oncology: H&O . 2016,第1期

机译：在没有EGFR突变的情况下，应将EGFR酪氨酸激酶抑制剂用于非小细胞肺癌吗？不可以，EGFR TKI应该保留给EGFR突变患者。
3. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer [J] . Gray Jhanelle E., Okamoto Isamu, Sriuranpong Virote, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第22期

机译：Flaura试验中的组织和血浆EGFR突变分析：Osimertinib与比较器EGFR酪氨酸激酶抑制剂作为EGFR-突变的晚期非小细胞肺癌患者的一线治疗
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Genetic and chemical modifiers of EGFR dependence in non-small cell lung cancer. [D] . Sharifnia, Tanaz. 2014

机译：非小细胞肺癌中EGFR依赖的遗传和化学修饰剂。
6. MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type [O] . Jiayu Li, Xuefei Li, Shengxiang Ren, 2014

机译：MiR-200c过表达与EGFR-TKIs在EGFR野生型非小细胞肺癌患者中具有更好的疗效相关
7. P2-066: Analysis of EGFR gene copy number, EGFR mutations, KRAS mutations and EGFR expression in a cohort of non-small cell lung cancer patients treated with epidermal growth factor tyrosine kinase inhibitors at a North American institution. [O] . Box Alan K., Otsuka Shannon, Morris Don, 2007

机译：P2-066：在北美一家机构中对使用表皮生长因子酪氨酸激酶抑制剂治疗的非小细胞肺癌患者队列中的EGFR基因拷贝数，EGFR突变，KRAS突变和EGFR表达进行了分析。

Overexpression of EGFR pathway-related genes in the circulation is highly correlated with EGFR mutations and overexpression in paired cancer tissue from patients with non-small cell lung cancer

著录项

引文网络

相似文献

相关主题

期刊订阅